Patient safety is of paramount importance in the pharmaceutical industry and if this is in any way compromised, companies face the spectre of product recalls, with all the costs for recall notification, product retrieval and liability, in addition to the potential damage to their brand and reputation. Industrial vision can play a key role in modifying the production process to help prevent the possibility of product recall.
At the time of writing, the Medicines & Healthcare products Regulatory Agency (MHRA) had issued 119 alerts and recalls for drugs and medical devices during 2015 and recalled 26 drugs, some of which were Class 2 recalls (to be implemented within 48hrs). Some of these are company-led recalls; others are as a result of problems identified in the field.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.